AG James Secures Another Agreement to Cap Insulin Prices for Uninsured New Yorkers
New York AG Letitia James entered an agreement with Novo Nordisk Inc. to resolve an investigation into insulin marketing and pricing practices. Under the terms of the agreement, Novo Nordisk will cap the price of their insulin products at $35 per monthly prescription for uninsured New Yorkers for a period of five years. The company…